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Abstract. The protective effects of Mucuna pruriens seed extract (MPE) against the
cardio-respiratory depressant and neuromuscular paralytic effects induced by injection
of Calloselasma rhodostoma (Malayan pit viper) venom in anaesthetized rats were
investigated. While MPE pretreatment did not reverse the inhibitory effect of the venom
on the gastrocnemius muscle excitability, it significantly attenuated the venom-induced
cardio-respiratory depressant effects (p<0.05). The protection effects may have an
immunological mechanism, as indicated by the presence of several proteins in the venom
that are immunoreactive against anti-MPE. However, we cannot rule out the possibility
that the pretreatment may exert a direct, non-immunological protective action against
the venom.
INTRODUCTION
Calloselasma rhodostoma (Malayan pit
viper) is a medically important snake
indigenous to Malaysia. The major toxins
of the pit viper venom are thrombin-like
enzymes, platelet-aggregation inducers
and inhibitors; as well as hemorrhagic
proteases (Tan, 1991). In recent years,
there has been a growing interest in
alternative therapies and the therapeutic
use of natural products, especially those
derived from plants. In almost any part of
the world, where venomous snakes occur,
numerous plant species are used as folk
medicine to treat snake bite (Mors, 1991;
Martz 1992; Houghton & Osibogun, 1993).
Mors (1991) stated that 578 species of
higher plants from 94 families have been
cited in the literature as being active
against snake bite.
Velvet beans (Mucuna pruriens. Also
known as Cowhage seed) are found in
Asia, America and Africa. The plant is
widely used as traditional medicine
(Sathiyanarayanan & Arulmozhi, 2007).
Acute and subacute toxicity studies on a
polyherbal formulation that include M.
pruriens suggested that the plant is safe for
treatment purpose (Chandra et al., 2007),
though it has been reported that
consumption of the unprocessed raw seed
is often accompanied by toxic symptoms
(Sathiyanarayanan & Arulmozhi, 2007). The
beans have been prescribed by traditional
practitioners in Nigeria as an oral
prophylactic for snakebites. The protective
effect of the aqueous M. pruriens seed
extract (MPE) has been demonstrated in
mice against the lethal effect of venoms
from Echis carinatus (saw-scaled viper)
(Aguiyi et al., 1999, Guerranti et al., 2002),
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Naja (cobra) and, to a lesser extent, C.
rhodostoma (Tan et al., 2009). In this paper,
we report the protective effect of M.
pruriens extract pretreatment against the
cardiovascular and respiratory depressant
effects of C. rhodostoma venom.
MATERIALS AND METHODS
Materials
Male Sprague Dawley rats and rabbits used
were supplied by the Central Animal
House, Faculty of Medicine, University of
Malaya. All animals were handled
according to guiding principles given by the
Council for International Organization of
Medical Sciences (CIOMS) on animal
experimentation (Howard-Jones, 1985).
Lyophilized C. rhodostoma crude venom
was obtained from Latoxan (Rosans,
France). Mucuna pruriens (family:
Fabaceae, subfamily: Papilionoideae,
genus: Mucuna, species: pruriens) seeds
were collected from Rukuba area in Jos,
Nigeria, with the aid of a traditional healer.
They were authenticated by Prof. S.W.H.
Hussini of the Department of Botany,
University of Jos. Voucher specimen
Number A102 is deposited in the Pharmacy
Herbarium of the University of Jos.
Molecular weight markers were obtained
from GE Healthcare (Singapore). All
chemicals and reagents used in this study
were of ACS grade and obtained from Sigma
(USA).
Preparation of Mucuna pruriens seed
extract (MPE)
Sun-dried seeds of M. pruriens were
ground to a paste of uniform consistency.
50 g of which were soaked in 100 ml of
deionized distilled water for 24 hrs at 4ºC,
and centrifuged at 10,000 x g for 20 min.
The supernatant was lyophilized to powder
known as M.pruriens extract (MPE) which
was stored at -4ºC and prepared freshly for
use.
Production of antibodies against
Mucuna pruriens seed extract
Rabbit was first bled from the marginal ear
vein for pre-immune sera. One rabbit
(approximately 2 kg) was used for
immunization. Rabbit was injected
intramuscularly with MPE at a dosage of 18
mg/kg (Aguiyi et al., 1999). The powdered
extract was dissolved in phosphate buffered
saline, pH 7.2. The homogeneous aqueous
was injected intramuscularly into the left
and right thighs of the rabbit alternatively
at 0, 3rd, 6th and 9th week. A booster
injection was given on week 12. A week
from the booster injection, the rabbit was
anesthetized and bled by cardiac puncture.
The pooled blood from the immunized
rabbit was allowed to clot for 1 hr at 37ºC,
after which it was transferred to 4ºC and
kept overnight, in order to contract the
blood clot. The serum was then removed
from the clot by centrifugation at 15,000
rpm for 20 min. IgG antibodies were purified
using protein A affinity chromatography as
described by Hudson & Hay (1980).
SDS-polyacrylamide gel electrophoresis
and Western blotting
SDS-polyacrylamide gel electrophoresis
was conducted according to Studier (1973).
iBlotTM Gel Transfer Device (Invitrogen)
was used. Polyacrylamide mini gel was
removed from the gel cassette and
assembled on the iBlot™ Gel Transfer
Device with the iBlot™ Gel Transfer
Stacks and transferred according to
manufacturer’s instructions. The membrane
was handled according to immuno-
detection protocol of the Western Breeze
(Invitrogen®).
Determination of the lethality of
Calloselasma rhodostoma venom
Lethality was determined by intravenous
injection of various amount of the venom
sample into the caudal veins of Sprague
Dawley rats (220 ± 10g). Five rats were
used at each dose level and the effect of the
368
venom was observed for 48 hours. Lethality
in rats was expressed in terms of LD50 (i.v.)
and was calculated according to the
Spearman-Karber method (WHO, 1981).
LD50 of C. rhodostoma was determined to
be 6.0 ± 0.1 mg/g body weight.
Pretreatment of rats with Mucuna
pruriens seed extract
The pretreatment of rats with M.pruriens
seed extract was carried out according to
Guerranti et al. (2002).  Rats were injected
with the extract at a dose of 21 mg/kg (i.p.),
once a week for three weeks (pretreatment
scheme) (Day 0, 7, 14). The untreated group
was injected with saline of a similar
volume.
Pharmacological studies (effects on
blood pressure, heart rate, respiratory
rate and muscle twitch tension) using
anesthetized rats
Pretreatment group consists of 9 rats
injected with whole seed extract at a dose
of 21 mg/kg (i.p.), once a week for three
weeks. The control (or untreated group)
was injected with saline of a similar
volume. After 21 days, the animals were
anesthetized and prepared for the
pharmacological experiments.
The rat was anesthetized with urethane
(1.4 g/kg) injected intraperitoneally. Its
trachea was cannulated to facilitate
spontaneous respiration. A lamp was used
to keep the animal warm. The common
carotid artery was cannulated (PE 25
tubing) for the monitoring of the systemic
blood pressure via a Statham pressure
transducer connected to a MacLab Data-
Acquisition system. The heart rate (HR)
was estimated from the blood pressure
(BP) recording. A syringe filled with
heparin (50 units/ml) was connected to one
outlet of the pressure transducer so as to
prevent clotting in the polyethylene
cannula and in the barrel of the pressure
transducer. The external jugular vein was
cannulated (PE 25 tubing) for the
administration of normal saline and venom.
The maximum volume used for intravenous
injection was 0.1 ml/100 g body weight of
rats.
A thread was tied to the skin just
below the diaphragm to monitor the
respiratory rate (RR) via a Grass-
compatible isometric force transducer
connected to a MacLab Data-Acquisition
system. The gastrocnemius was separated
from other adjacent muscles. A thread was
tied onto its Achilles tendon which was
then cut to free the isolated gastrocnemius.
The thread tying the tendon was connected
to another channel of the physiograph
recorder via another isometric force
transducer for the recording of skeletal
muscle contractions. The sciatic nerve
innovating the gastrocnemius was detected
and carefully hooked to an electrode. The
contractions of the gastrocnemius were
elicited through the stimulation of the
sciatic nerve at a frequency of 0.1 Hz, a
pulse width of 0.5 milliseconds and at
supramaximal voltage of 3-8 V. A resting
tension of 3-6 g was applied to the
gastrocnemius before stimulation
commenced.
The systemic blood pressure,
respiratory movement and gastrocnemius
muscle contractions were monitored
simultaneously for at least 30 minutes to
ensure stabilization of these parameters.
After stabilization, C. rhodostoma venom
(3.0 mg/g) was administered intravenously
into the rats through the external jugular
vein. The blood pressure, heart rate and the
skeletal muscle contractions were
measured at stipulated time. The normal
arterial blood pressure of the anesthetized
rat was calculated as the mean blood
pressure (mBP) using the formula:
Anesthetized rat experiments were usually
carried out on a pair of animals (a treated
and an untreated rat) simultaneously each
time.
After venom injection, the blood
pressure, heart rate, respiratory rate and
muscle twitch tension were measured at an
interval of 10 seconds for the first 5 mins
and finally every min thereafter up to 30
mins after venom injection or until the rat
died.
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Statistical analysis
All biological data are presented as mean
S.E.M. of (n) experiments. Differences in
the means between groups were analyzed
using unpaired Student’s t test with P < 0.05
considered as significant. The analysis
were carried out using a Biostat Analysis
package.
RESULTS
Western blotting studies of the
immunological cross reactions of
Calloselasma rhodostoma venom with
anti-Mucuna pruriens IgG
Anti- M. pruriens IgG cross reacted with
various protein components of the C.
rhodostoma venom. The immunoreactive
protein components range from high
molecular weight proteins (175,000 Da) to
low molecular weight proteins (7,000 Da)
(Fig. 1). The identity of cross-reacting
proteins was not identified.
Effects of MPE pretreatment on the
cardiorespiratory depressant effects
and neuromuscular paralysis induced
by Calloselasma rhodostoma venom
The effects of C. rhodostoma venom on
blood pressure, heart rate, respiratory rate
and muscle twitch tension of the MPE-
treated and untreated rats are shown in
Figure 2A-2D.
a. Protection against venom-induced
cardiovascular depression
Calloselasma rhodostoma venom at half-
LD50 caused a significant cardiovascular
depression in the control (untreated) group
of anesthetised rats (Fig. 2A and 2B). There
was a marked reduction in the heart rate
(from 390.0 ± 10.0 to 183.3 ± 38.9 beats/
min) and blood pressure (from 102.1 ± 5.2
mmHg to 47.8 ± 9.1 mmHg) within the first
half to one minute. After this transient
marked fall in the cardiovascular activities,
the animals recovered partially for a brief
moment (about 1-2 min) before further
progressive decrease of both heart rate and
blood pressure from then on until the
animals died or the end of the 30-min
monitoring period (2 animals survived).
Marked fluctuations of heart rate were also
observed during this monitoring period.
Pretreatment with MPE conferred a
significant, protective effect against the
cardiodepressant effects of the venom; the
protection being more significant on the
heart rate than on the blood pressure. At 30
min, the blood pressure and heart rate of
the treated rats remained at 54.3 ± 11.2
mmHg and 156.3 ± 50.3 bpm (beats per
min), respectively. In comparison, the
average BP and HR of the untreated animals
Figure 1. Cross reactions of proteins from
Calloselasma rhosdostoma venom with anti-
MPE IgG by Western blotting analysis
Lane 1: SDS-PAGE of broad range protein
standards (from top): myosin (200, 768 Da); β-
galactosidase (115, 281 Da); bovine serum
albumin (96, 190 Da); ovalbumin (51, 783 Da);
carbonic anhydrase (37, 659 Da); soybean trypsin
inhibitor (29, 054 Da); lysozyme (20, 461 Da) and
aprotinin (7,100 Da). Lane 2 : SDS-PAGE of
Calloselasma rhodostoma venom.  Lane 3:
Western blotting analysis. The immunoreactive
bands have molecular weights ranging from 7 kDa
to 175 kDa
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dropped to 21.6 ± 9.6 mmHg and 12.5 ± 3.2
bpm, respectively.
b. Protection against venom-induced
decline in respiratory rate
The crude C. rhodostoma venom caused
a significant decline in the respiratory rate
of the rats, even though at the beginning
there was a transient, slight increase in the
respiratory rate (Fig. 2C). At 30 min, the
average respiratory rate dropped to 19.3 ±
2.5 per min. MPE-pretreatment conferred
significant protection against the venom-
induced respiratory depression: at 30 min
post injection of venom, the respiratory rate
remained at 73.4 ± 11.2 per min, only about
30% lower than control.
c. Protection against venom-induced
neuromuscular paralysis
Upon injection of the venom, blockade of
nerve-evoked muscle twitches occurred
promptly and worsened progressively until
the animals died or the end of the 30-min
monitoring period (Fig. 2D). However,
unlike the effects observed with venom-
induced cardiovascular and respiratory
activities, MPE-pretreatment did not
protect against the venom-induced
neuromuscular paralysis (16.9 ± 7.5%
versus 43.5 ± 11.5%, p>0.05, at 30 min)
(Fig. 2D).
DISCUSSION
Tan et al. (2009) reported that pre-
treatment with M. pruriens seed extract
(MPE) conferred effective protection
against the lethality of Naja (cobra) venoms
and moderate protection against C.
rhodostoma venom. Indirect ELISA studies
showed that there were cross-reactions
between anti-MPE IgG and C. rhodostoma
Figure 2. Effect of MPE-pretreatment on the cardio-respiratory depressant effects and
neuromuscular paralysis induced by Calloselasma rhodostoma venom in rats
Rats (MPE-pretreated and controls) were injected with ½ LD50 (3.0 mg/kg, i.v.) of crude Calloselasma
rhodostoma venom. The effects on blood pressure (A), heart rate (B), respiratory rate (C) and muscle
twitch tension (D) (mean ± S.E. n=9) were measured
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venom, and in vitro neutralization studies
suggested that the protective action of
MPE probably involves immunological
mechanism. In the present studies, result of
Western blotting confirmed that there were
indeed cross-reactions between anti-M.
pruriens IgG and many protein components
of the C. rhodostoma venom. The reactive
proteins include proteins with molecular
weight ranging from 7 kDa to 200 kDa. The
identity of the immunological reactive
venom proteins, however, has not been
established. These results are consistent
with the studies by Guerranti et al. (2002)
who demonstrated that the prophylactic
protective action of MPE against E.
carinatus venom is due to the production
of specific antibodies in the treated animals
that could neutralize certain E. carinatus
venom components.
Injection of ½ LD50 dose of C.
rhodostoma venom into the anesthetized
rats induced marked depression of
cardiovascular, respiratory and
neuromuscular activities in the animals.
Since there have been no reported
presence of cardiotoxins or neurotoxins in
the C. rhodostoma venom (Tan, 1991),
these venom-induced cardiovascular,
respiratory and neuromuscular changes
may be secondary to the venom’s multiple
effects on hemostasis via its thrombin-like
enzymes, hemorrhagins, platelet
aggregation inducers and inhibitors (Tan
1991), which result in extensive systemic
bleeding internally followed by circulatory
shock. The decreased blood perfusion to
the various tissues and organs concerned
(e.g. heart, lungs and skeletal muscles)
may indirectly reduce their activities as a
result of tissue ischemia. It is of interest to
note that the neuromuscular paralytic effect
caused by C. rhodostoma venom occurred
more gradually following cardiovascular
depression and often worsened much more
rapidly after the death of animals. This
suggests that the neuromuscular paralysis
observed in experimental C. rhodostoma
envenomation is the consequence of poor
muscle perfusion caused by marked
circulatory failure. It is, however, also
conceivable that the phospholipase A2
enzymes present in C. rhodostoma venom
may have contributed to some of the
observed venom-induced depressant
effects on the heart and skeletal muscles.
Our results showed that while MPE-
pretreatment did not reverse the inhibitory
effect of C. rhodostoma venom on the
gastrocnemius muscle excitability, it
significantly attenuated (albeit partially)
the cardiorespiratory depressant effects of
the venom. The protection against
cardiorespiratory depressant effects may
have an immunological mechanism, as
earlier in vitro neutralization studies
indicated that anti-MPE was able to
neutralize C. rhodostoma venom partially
(Tan et al., 2009), and our Western blotting
studies did demonstrate the presence of
several proteins in the venom that are
immune-reactive against anti-MPE.
However, we cannot rule out the possibility
that the pretreatment may exert a direct,
non-immunological protective action
against C. rhodostoma venom.
In conclusion, our studies suggest that
injection of MPE confers protection against
C. rhodostoma venom, as the pretreatment
attenuated (albeit only partially) the
cardio-respiratory depressant effects of C.
rhodostoma venoms in anesthetized rats.
Together with the results of Guerranti et al.
(2004) and Tan et al.(2009), our results
suggest that pretreatment with M. pruriens
seed extract may confer protective action
against the toxic effects of a wide spectrum
of snake venom.
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